NO964291L - Fremgangsmåte for behandling av allergisk rinitt - Google Patents

Fremgangsmåte for behandling av allergisk rinitt

Info

Publication number
NO964291L
NO964291L NO964291A NO964291A NO964291L NO 964291 L NO964291 L NO 964291L NO 964291 A NO964291 A NO 964291A NO 964291 A NO964291 A NO 964291A NO 964291 L NO964291 L NO 964291L
Authority
NO
Norway
Prior art keywords
treatment
procedure
allergic rhinitis
peptido
antihistamine
Prior art date
Application number
NO964291A
Other languages
English (en)
Norwegian (no)
Other versions
NO964291D0 (no
Inventor
Theodore J Torphy
Egbert De Jong
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO964291D0 publication Critical patent/NO964291D0/no
Publication of NO964291L publication Critical patent/NO964291L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO964291A 1994-04-12 1996-10-09 Fremgangsmåte for behandling av allergisk rinitt NO964291L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9407335A GB9407335D0 (en) 1994-04-12 1994-04-12 Method of treatment
PCT/US1995/004376 WO1995027487A1 (en) 1994-04-12 1995-04-10 Method of treating allergic rhinitis

Publications (2)

Publication Number Publication Date
NO964291D0 NO964291D0 (no) 1996-10-09
NO964291L true NO964291L (no) 1996-12-05

Family

ID=10753480

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964291A NO964291L (no) 1994-04-12 1996-10-09 Fremgangsmåte for behandling av allergisk rinitt

Country Status (15)

Country Link
EP (1) EP0755252A4 (pt)
JP (1) JPH09511988A (pt)
CN (1) CN1149828A (pt)
AP (1) AP561A (pt)
AU (1) AU2381295A (pt)
BR (1) BR9507353A (pt)
CZ (1) CZ295396A3 (pt)
GB (1) GB9407335D0 (pt)
HU (1) HUT75940A (pt)
IL (1) IL113293A0 (pt)
MA (1) MA23503A1 (pt)
NO (1) NO964291L (pt)
PL (1) PL316850A1 (pt)
WO (1) WO1995027487A1 (pt)
ZA (1) ZA952932B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
KR20050008391A (ko) * 2003-07-15 2005-01-21 삼성전자주식회사 화질개선장치 및 그 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261835A (en) * 1984-08-20 1989-09-26 Masaaki Toda (fused) benz(thio)amides
US5276044A (en) * 1991-08-14 1994-01-04 Allergan, Inc. Leukotriene receptor antagonist and antihistamine complex pharmaceutical compositions

Also Published As

Publication number Publication date
NO964291D0 (no) 1996-10-09
IL113293A0 (en) 1995-07-31
AP9500729A0 (en) 1995-04-30
EP0755252A1 (en) 1997-01-29
CZ295396A3 (en) 1997-08-13
HU9602786D0 (en) 1996-11-28
AP561A (en) 1996-11-15
HUT75940A (en) 1997-05-28
EP0755252A4 (en) 1997-07-30
JPH09511988A (ja) 1997-12-02
GB9407335D0 (en) 1994-06-08
BR9507353A (pt) 1997-09-23
ZA952932B (en) 1995-12-20
AU2381295A (en) 1995-10-30
CN1149828A (zh) 1997-05-14
WO1995027487A1 (en) 1995-10-19
MA23503A1 (fr) 1995-12-31
PL316850A1 (en) 1997-02-17

Similar Documents

Publication Publication Date Title
DK0531410T3 (da) (+)-alfa-(2,3-Demethoxyphenyl)-1-(2-(4-fluorphenyl)ethyl)-4-piperidinmethanol
FI934223A (fi) Heterocykliscykliska aminderivat
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
DE69620306D1 (de) 4-(.Alpha.-hydroxy-.alpha.-aryl-alkylcarbonylamino)-Piperidine zur Behandlung und Prophylaxe von Erkrankungen der Harnwege
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
MY116130A (en) Treatment of upper airway allergic responses
NO993847D0 (no) Fremgangsmåter og sammensetninger for behandling av allergisk astma og andre sykdommer som anvender deskarboetoksyloratadin
NO904595D0 (no) Fremgangsmaate for potensiering av den analgetiske effekt av curcuminoid.
DE60139466D1 (de) Behandlung von diabetes
FI953899A0 (fi) Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
DE69622472D1 (de) Behandlung von Krankheiten durch Induktion von BEF-1 Transkriptionsfaktor
NO982867L (no) Nye substituerte 4-(1H-benzimidazol-2-yl)£1,4|diazepaner som er anvendbare for behandling av allergiske sykdommer
NO964291L (no) Fremgangsmåte for behandling av allergisk rinitt
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DE69736180D1 (de) Behandlung von manischen erkrankungen
FR2707990B1 (fr) Nouvelles nitrones utilisables pour le piégeage des radicaux libres.
DE59106803D1 (de) Substituierte Pyrido-oxazine.
DK0496274T3 (da) Tricyclisk pyridonderivat
FI906162A (fi) Foerfarande foer framstaellning av 3-(n-metyl-n-alkyl)-amino-2-metoximetylenpropan-1-olderivat.
NO911465L (no) Fremgangsmaate for fremstilling av 4-(3-(4-oksotiazoldinyl))-butynylaminer og deres anvendelse som medikamenter.
TR200003084T2 (tr) Paroxetine askorbat
MX9604731A (es) Uso de un antagonista de peptidoleucotrieno y una antihistamina y composicion que los contiene.
IT1288184B1 (it) Procedimento per l'accorciamento del tempo di chiusura e dispositivo per l'attuazione del procedimento.
SI0874843T1 (en) Substituted 4-(1h-benzimidazol-2-yl) 1,4)diazepanes useful for the treatment of allergic diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application